In 2024, the global Human Papillomavirus testing market (ヒトパピローマウイルス検査市場) is estimated at US$ 1,214.0 million, with a projected compound annual growth rate (CAGR) of 10.3% through 2034. This growth trajectory suggests a market size of US$ 3,236.3 million by 2034. HPV testing has become crucial for preventing and detecting cervical cancer, a common cancer among women worldwide....